Chemically induced infection of CD4-negative HeLa cells with HIV-1

Microbiology and Immunology

Volumn 43, Issue 12, 1999, Pages 1077-1086

  Harada, Shinji ^a,b   Maeda, Yosuke ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

AIDS; HIV 1; Poly L lysine; Receptor

Indexed keywords

CD4 ANTIGEN; CELL MEMBRANE PROTEIN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; POLYLYSINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; HELA CELL; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS ENVELOPE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033390224     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1999.tb03364.x     Document Type: Article

References (41)

1. Bandres, J.C., Wang, Q.F., O'leary, J., Baleaux, F., Amara, A., Hoxie, J.A., Zolla-Pazner, S., and Gorny, M.K. 1998. Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation. J. Virol. 72: 2500-2504.
2. Bernier, R., Barbeau, B., Tremblay, M.J., and Olivier, M. 1998. The lipophosphoglycan of Leishmania donovani upregulates HIV-1 transcription in T cells through the nuclear factor-κB elements. J. Immunol. 160: 2881-2888.
3. Bullough, P.A., Hughson, F.M., Skehel, J.J., and Wiley, D.C. 1994. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371: 37-43.
4. Carr, C.M., and Kim, P.S. 1993. A spring-loaded mechanism for the conformational changes of influenza hemagglutinin. Cell 73: 823-832.
5. Chan, D.C., Fass, D., Berger, J.M., and Kim, P.S. 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89: 263-273.
6. Davis, C.B., Dikic, I., Unutmaz, D., Hill, CM., Arthos, J., Siani, M.A., Thompson, D.A., Schlessinger, J., and Littman, D.R. 1997. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J. Exp. Med. 186: 1793-1798.
7. Dimitrov, D.S. 1997. How do viruses enter cells? The HIV coreceptors teach us a lesson of complexity. Cell 91: 721-730.
8. Feng, Y., Broder, C.C., Kennedy, P.E., and Berger, E.A. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane domain, G-protein coupled receptor. Science 272: 872-877.
9. Flory, E., Weber, C.K., Chen, P. Hoffmeyer, A., Jassoy, C., and Rapp, U.R. 1998. Plasma membrane-targeted Raf kinase activates NF-κB and human immunodeficiency virus type 1 replication in T lymphocytes. J. Virol. 72: 2788-2794.
10. Fortin, J., Cantin, R., Lamontagne, G., and Tremblay, M. 1997. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J. Virol. 71: 3588-3596.
11. Fortin, J., Cantin, R., and Tremblay, M.J. 1998. T cell expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1. J. Virol. 72: 2105-2112.
12. Fu, Y.K., Hart, T.K., Jonak, Z.L., and Bugelski, P.J. 1993. Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120. J. Virol. 67: 3818-3825.
13. Hanenberg, H., Xiao, X.L., Dilloo, D., Hashino. K., Kato, I., and Williams, D.A. 1996. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat. Med. 2: 876-882.
14. Harada, S., Koyanagi, Y., Nakashima, H., Kobayashi, N., and Yamamoto, N. 1986. Tumor promoter, TPA, enhances replication of HTLV-III/LAV. Virology 154: 249-258.
15. Harada, S., Koyanagi, Y., and Yamamoto, N. 1985. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229: 563-566.
16. Hattori, T., Koito, A., Takatsuki, K., Kido, H., and Katunuma, N. 1989. Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection. FEBS Lett. 248: 48-52.
17. Hoffman, T.L., and Doms, R.W. 1998. Chemokines and coreceptors in HIV/SIV-host interactions. AIDS 12 (suppl A): S17-S26.
18. Hu, H., Shioda, T., Moriya, C., Xin, X., Hasan, M.K., Miyake, K., Shimada, T., and Nagai, Y. 1996. Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface. J. Virol. 70: 7462-7470.
19. Judice, J.K., Tom, J.Y.K., Huang, W., Wrin, T., Vennari, J., Petropoulos, C.J., and McDowell, R.S, 1997. Inhibition of HIV type 1 infectivity by constrained α-helical peptides: implications for the viral fusion mechanism. Proc. Natl. Acad. Sci. U.S.A. 94: 13426-13430.
20. Kimpton, J., and Emerman, M. 1992. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66: 2232-2239.
21. Koyanagi, Y., Harada, S., and Yamamoto, N. 1986. Establishment of a high production system for AIDS retroviruses with a human T-leukemic cell line MOLT-4. Cancer Lett. 30: 299-310.
22. Kwong, P.D., Wyatt, R., Robinson, J., Sweet, R.W., Sodroski, J., and Hendrickson, W.A. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393: 648-659.
23. Laquerre, S., Argnani, R., Anderson, D.B., Zucchini, S., Manservigi, R., and Glorioso, J.C. 1998. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J. Virol. 72: 6119-6130.
24. Maddon, P.J., McDougal, J.S., Clapham, P.R., Dalgleish, A.G., Jamal, S., Weiss, R.A., and Axel, R. 1988. HIV infection does not require endocytosis of its receptor. CD4. Cell 54: 865-874.
25. Minowada, J., Ohnuma, T., and Moore, G.E. 1972. Rosette forming human lymphoid cell line. I. Establishment and evidence for origin of thymus-derived lymphocytes. J. Natl. Cancer Inst. 49: 891-895.
26. Mondor, I., Ugolini, S., and Sattentau, Q.J. 1998. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. J. Virol. 72: 3623-3634.
27. Moore, J.P., McKeating, J.A., Weiss, R.A., and Sattentau, Q.J. 1990. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250: 1139-1142.
28. Moriuchi, H., Moriuchi, M., and Fauci, A.S. 1998. Factors secreted by human T lymphotropic virus type I (HTLV-I)-infected cells can enhance or inhibit replication of HIV-1 in HTLV-I-uninfected cells: implications for in vivo coinfection with HTLV-I and HIV-I. J. Exp. Med. 187: 1689-1697.
29. Morizono, K., and Harada, S. 1998. Human immunodeficiency virus type 1 (HIV-1) infection and transcytosis activity of a HIV-1 susceptible clone from HeLa cell. Microbiol. Immunol. 42: 313-320.
30. Nabel, G., and Baltimore, D. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326: 711-713.
31. Nakamura, T., Masuda, T., Goto, T., Sano, K., Nakai, M., and Harada, S. 1997. Lack of infectivity of HIV-1 integrase zinc finger-like domain mutant with morphologically normal maturation. Biochem. Biophys. Res. Commun. 239: 715-722.
32. Popik, W., Hesselgesser, J.E., and Pitha, P.M. 1998. Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway. J. Virol. 72: 6406-6413.
33. Stein, B.S., Gowda, S.D., Lifson, J.D., Penhallow, R.C., Bensch, K.G., and Engleman, E.G. 1987. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 49: 659-668.
34. Sullivan, N., Sun, Y., Sattentau, Q., Thali, M., Wu, D., Denisova, G., Gershoni, J., Robinson, J., Moore, J., and Sodroski, J. 1998. CD4-induced conformational changes in the human immunodeficiency virus type 1 gp 120 glycoprotein: consequences for virus entry and neutralization. J. Virol. 72: 4694-4703.
35. Sundstrom, C., and Nilsson, K. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17: 565-577.
36. Talbot, S., Weiss, R., and Schulz, T. 1995. Reduced glycosylation of human cell lines increases susceptibility to CD4-independent infection by human immunodeficiency virus type 2 (LAV-2/B). J. Virol. 69: 3399-3406.
37. Thali, M., Furman, C., Helseth, E., Repke, H., and Sodroski, J. 1992. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events. J. Virol. 66: 5516-5524.
38. Toyoshima, K., and Vogt, P.K. 1969. Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions. Virology 38: 414-426.
39. Willey, R.L., Martin, M.A., and Peden, K.W. 1994. Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1. J. Virol. 68: 1029-1039.
40. Wyatt, R., Kwong, P.D., Desjardins, E., Sweet, R.W., Robinson, J., Hendrickson, W.A., and Sodroski, J.G. 1998. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393: 705-711.
41. Zack, J.A., Arrigo, S.J., Weitsman, S.R., Go, A.S., Haislip, A., and Chen, I.S.Y. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61: 213-222.